S062 Grand Challenges in Global Skin Health - The Atlases
DESCRIPTION
The ILDS Grand Challenges in Global Skin Health works closely with the World Health Organization to elucidate the global epidemiology of the inflammatory skin diseases psoriasis, atopic dermatitis, vitiligo and hidradenitis suppurativa through its four cognate atlases. By so doing this provides robust evidence on the prevalence, understanding and access to care for these diseases that affect more than 250 million people worldwide.
LEARNING OBJECTIVES
Discuss the worldwide epidemiology of inflammatory skin diseases and thereby enhance recognition of these as serious non-communicable diseases deserving of greater recognition
Recognize the ILDS Grand Challenges in Global Skin Health and the 78th World Health Assembly resolution on skin disease as a global health priority
Evaluate the roles of the Skin Observatory and the Global Atlases in enhancing access to care for skin disease worldwide
SCHEDULE
1:00 PM
Welcome and Introduction
Christopher E. M. Griffiths, MD, IFAAD
1:05 PM
ILDS and Global Dermatology
Henry W. Lim, MD, FAAD
1:30 PM
The WHO Resolution - Skin Disease is a Global Health Priority
Claire Fuller, MD, IFAAD
1:55 PM
The Global Psoriasis Atlas - a Pioneer
Christopher E. M. Griffiths, MD, IFAAD
2:20 PM
The Global Atopic Dermatitis Atlas – Filling Burden Gaps Worldwide
Carsten Flohr
2:45 PM
The GLObal Vitiligo Atlas : Severity, Disease Burden and Work-Related Impact
Khaled Ezzedine, MD, PhD, IFAAD
2:55 PM
The GLObal Vitiligo Atlas : Severity, Disease Burden and Work-Related Impact
Viktoria Eleftheriadou, MD, PhD
3:10 PM
Global Hidradenitis Suppurativa Atlas - Bringing the World Together
Gregor B.E. Jemec, MD, IFAAD
3:35 PM
Mapping Access to Care Worldwide: the Skin Health Observatory Study
Esther Ellen Freeman, MD, PhD, FAAD
DIRECTOR
Christopher E. M. Griffiths, MD, IFAAD
SPEAKERS
Viktoria Eleftheriadou, MD, PhD
Khaled Ezzedine, MD, PhD, IFAAD
Carsten Flohr
Esther Ellen Freeman, MD, PhD, FAAD
Claire Fuller, MD, IFAAD
Gregor B.E. Jemec, MD, IFAAD
Henry W. Lim, MD, FAAD
DISCLOSURES
Viktoria Eleftheriadou, MD, PhD
No financial relationships exist with ineligible companies.
Khaled Ezzedine, MD, PhD, IFAAD
AbbVie – Advisory Board(Fees); BMS – Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Honoraria);
Carsten Flohr
No financial relationships exist with ineligible companies.
Esther Ellen Freeman, MD, PhD, FAAD
American Academy of Dermatology – Advisory Board(No Compensation Received); British Journal of Dermatology – Other(Salary); CeraVe – Advisory Board(Honoraria); Harvard University – Speaker(Honoraria); International League of Dermatologic Societies – Investigator(Grants/Research Funding); L'Oreal – Advisory Board(Honoraria); National Institutes of Health – Investigator(Grants/Research Funding); UpToDate, Inc – Other(Honoraria);
Claire Fuller, MD, IFAAD
L'Oreal UK & Ireland – Employee(Salary);
Christopher E. M. Griffiths, MD, IFAAD
AbbVie – Speaker(Honoraria); Almirall – Investigator(Fees), Investigator(Grants/Research Funding); Artax Biopharma – Data Safety Monitoring Board(Fees); Boots – Advisory Board(Honoraria); Bristol-Myers Squibb – Speaker(Honoraria); Celltrion – Advisory Board(Fees); Eli Lilly and Company – Speaker(Honoraria); Glenmark Pharmaceuticals, Inc. – Speaker(Honoraria); Johnson and Johnson – Speaker(Honoraria); Leo Foundation – Investigator(Grants/Research Funding); Novartis – Speaker/Faculty Education(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker(Honoraria); The Skin Diary – Board of Directors(Stock Options); UCB – Speaker(Honoraria); Wiley & Sons, Inc. – Other(Fees);
Gregor B.E. Jemec, MD, IFAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Astion Pharma – Consultant(Honoraria); Desitin Arzneimittel GmbH – Speaker/Faculty Education(No Compensation Received); InflaRx GmbH – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Janssen-Ortho Inc. – Investigator(Grants/Research Funding); LEO Pharma, US – Investigator(Grants/Research Funding); Michelson Diagnostics Ltd. – Investigator(No Compensation Received); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Henry W. Lim, MD, FAAD
Beiersdorf, Inc. – Consultant(Fees); Boehringer Ingelheim – Advisory Board(Honoraria); Cantabria Labs – Speaker(Fees); Clinuvel – Speaker(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); ISDIN – Consultant(Fees); Kenvue – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); La Roche-Posay – Investigator(Grants/Research Funding); La Roche-Posay Laboratoire Pharmaceutique – Speaker/Faculty Education(Fees); NAOS – Speaker(Fees); Patient-Centered Outcomes Research Institute – Investigator(Grants/Research Funding); PCORI – Investigator(Fees); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Rxilient – Speaker(Fees); Skinosive – Consultant (1099 relationship)(Fees);